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Letters
Glaucoma Considered as an Imbalance
Between Production and Clearance of
Neurotoxins
We read with great interest the paper by Yang et al.1 titled
‘‘Optic Neuropathy Induced by Experimentally Reduced
Cerebrospinal Fluid Pressure in Monkeys’’ published recently
in Investigative Ophthalmology & Visual Science. We are
grateful to the authors for sharing their findings with the
scientific community, and we appreciate the opportunity to
comment on an issue raised by the authors.
To examine the influence of experimentally reduced
cerebrospinal fluid (CSF) pressure on retinal nerve fiber layer
(RNFL) thickness and neuroretinal rim area of the optic nerve
head, Yang et al.1 conducted a study on monkeys subjected to
an implantation of a lumbar-peritoneal CSF shunt. In the study
group (n¼ 4 monkeys), the shunt was opened to achieve a CSF
pressure of approximately 40 mm H2O, while the shunt
remained closed in the control group (n¼ 5 monkeys). During
a follow-up of 1 year, two out of the four monkeys of the active
intervention group showed a progressive reduction in RNFL
thickness in both of their eyes, accompanied by a significant
reduction in the area and volume of the neuroretinal rim and a
significant increase in the cup-to-disc area ratio. Two monkeys
with artificially low CSF pressure did not develop the optic
neuropathy observed in the other two monkeys, nor did any
monkey of the control group. The authors emphasized that
they did not examine any morphological changes in the lamina
cribrosa of the monkeys, and therefore concluded that their
study did not present any evidence that low CSF pressure
caused glaucoma at normal levels of intraocular pressure (IOP).
Their study, however, supported the concept that low CSF
pressure alone may cause retinal ganglion cell injury and loss
and thus that a low CSF pressure may be a risk factor in all
forms of optic neuropathy including glaucoma.
The hypothesis of low CSF pressure, that is, intracranial
pressure (ICP), as pathogenically important for glaucoma has
attracted much attention in recent years. A growing body of
evidence indicates that ICP is lower in patients with primary
open-angle glaucoma and normal-tension glaucoma when com-
pared with nonglaucomatous control subjects.2–4 These findings
support the notion that the relationship between IOP and ICP
may play a fundamental role in the development of glaucoma.5 A
decreased ICP, leading to an abnormally high translamina cribrosa
pressure difference (TLCPD), could result in barotraumatically
induced optic nerve damage at the lamina cribrosa. Conversely,
recent studies have reported that ICP is higher in patients with
ocular hypertension (OHT) compared with controls, giving rise
to the idea that this elevated ICP may provide a protective effect
for the optic nerve by decreasing the TLCPD.3,6
With regard to the potential pathogenic role of an abnormally
low CSF pressure in the development of optic nerve damage, a
remaining question is why two monkeys with artificially low CSF
pressure from the study by Yang et al.1 did not develop an optic
neuropathy. According to the authors, one explanation could be
that the absence of optic neuropathy in these animals was similar
to the clinical observation of OHT, in which despite elevated IOP
an optic nerve damage does not develop.1 In other words, some
of the protective factors for OHT may also operate in these two
monkeys. This is completely in line with the viewpoint
presented in a paper by our group that is being prepared for
publication (Wostyn P, et al., manuscript in preparation, 2014).
In this opinion article, based on current literature, we postulate
that enhanced CSF turnover and clearance may protect against
elevated IOP. Previous findings at least suggest that high IOP may
generate neurotoxins that could then be cleared via the CSF.7–13
b-amyloid (Ab) accumulation, one of the key histopathologic
findings in Alzheimer’s disease (AD), has been reported to
increase by chronic elevation of IOP in animals with experi-
mentally induced OHT and to cause retinal ganglion cell death,
pointing to similarities in molecular cell death mechanisms
between glaucoma and AD.7,8 On the other hand, previous
studies investigating the flow of fluids in the anterior part of the
optic nerve demonstrated that the fluids from the vitreous body
and the optic nerve move from opposite directions and converge
at the optic nerve head.9,10 Indeed, first of all, several studies
found that there is a backward bulk flow of fluid from the
vitreous into the optic nerve head.9–11 In addition, several
studies established that there is a flow of fluid from the
subarachnoid space of the optic nerve into the optic nerve and
optic nerve head.9,10,12,13 This at least suggests that the optic
nerve subarachnoid CSF exchanges with its interstitial fluid
compartment, which may facilitate clearance of interstitial
solutes, including Ab. Given the upregulation of Ab and other
putative neurotoxins after IOP elevation, rapid CSF production
and hence faster CSF circulation could exert protective effects
against glaucoma. This might explain the higher CSF pressure
reported in subjects with OHT,3,6 given that the CSF pressure is
the resultant of the production and outflow of CSF. Our
viewpoint argues that glaucoma, just like AD, may occur when
there is an imbalance between production and clearance of
neurotoxins, including Ab. If indeed CSF is involved in the
clearance of solutes and wastes from the optic nerve, then
strategies to improve CSF flow could provide a new therapeutic
approach in glaucoma. This view seems to be supported by the
findings from the study by Yang et al.1 Indeed, a possible
explanation for the absence of optic neuropathy in two monkeys
with artificially low CSF pressure could be altered CSF dynamics
related to shunt placement, that is, increased CSF flow from the
ventricles, leading to enhanced removal of potentially neurotox-
ic waste products that accumulate in the optic nerve. Although
the reduction in CSF pressure by the lumbar-peritoneal CSF
shunt may increase the risk of developing optic neuropathy,
shunt placement may also have a protective effect due to
increased CSF turnover and clearance. We believe that this may
explain why two monkeys with artificially low CSF pressure did
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